Wearable Technology to Assess Gait Function in SMA and DMD
study id #: NCT04193085
condition: Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy
status: Recruiting
purpose:The purpose of this project is to devise instrumented insoles capable of accurately measuring gait at each footfall, over multiple hours in any environment. To achieve high accuracy, the investigators will develop a new learning-based calibration framework. Features will be tested in controlled lab settings 39 during a single visit in people with SMA (13), DMD (13) and healthy controls (13) and in 15 participants in real-life environments.
results: https://clinicaltrials.gov/ct2/show/results/NCT04193085
last updated: February 04, 2022
-
Spinal Muscular Atrophy (SMA)Spinal muscular atrophy (SMA) is a genet...
-
Managing Pregnancy in a Spinal Muscular Atrophy Type III Patient in Indonesia: A Case ReportSpinal muscular atrophy (SMA) is a genet...
-
Integrating Newborn Screening for Spinal Muscular Atrophy Into Health Care Systems: An Australian Pilot ProgrammeAim: This study dynamically designed, ev...
-
FDA Lifts Partial Clinical Hold on Novartis’ SMA Drug ProgrammeThe US Food and Drug Administration (FDA...
-
Artist With SMA Pens Song ‘SPACES’ About Looking Beyond DisabilityA song written and performed by an artis...
-
Stanford Healthcare – Spinal Muscular AtrophyStanford Neuromuscular Program has exten...
-
The SMA France National Registry: Already Encouraging ResultsSpinal muscular atrophy is a debilitatin...